These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34866212)

  • 1. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
    Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
    Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults.
    Collyer TA; Murray AM; Woods RL; Storey E; Chong TT; Ryan J; Orchard SG; Brodtmann A; Srikanth VK; Shah RC; Callisaya ML
    JAMA Netw Open; 2022 May; 5(5):e2214647. PubMed ID: 35639376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of incident stroke on cognitive trajectories in later life.
    Vishwanath S; Hopper I; Cloud GC; Chong TT; Shah RC; Donnan GA; Williamson JD; Eaton CB; Wolfe R; Reid CM; Tonkin AM; Orchard SG; Fitzgerald S; Murray AM; Woods RL; Nelson MR; Sood A; Steves CJ; Ryan J
    Alzheimers Res Ther; 2024 May; 16(1):111. PubMed ID: 38762556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-Retest Reliability and Minimal Detectable Change of Four Cognitive Tests in Community-Dwelling Older Adults.
    Webb KL; Ryan J; Wolfe R; Woods RL; Shah RC; Murray AM; Orchard SG; Storey E
    J Alzheimers Dis; 2022; 87(4):1683-1693. PubMed ID: 35491779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
    Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
    Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
    Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults.
    Lockery JE; Broder JC; Ryan J; Stewart AC; Woods RL; Chong TT; Cloud GC; Murray A; Rigby JD; Shah R; Storey E; Ward SA; Wolfe R; Reid CM; Collyer TA; Ernst ME;
    J Gen Intern Med; 2021 Jun; 36(6):1629-1637. PubMed ID: 33754317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
    Novella A; Elli C; Ianes A; Pasina L
    Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal associations of anticholinergic medications on cognition and possible mitigating role of physical activity.
    Norling AM; Bennett A; Crowe M; Long DL; Nolin SA; Myers T; Del Bene VA; Lazar RM; Gerstenecker A
    J Am Geriatr Soc; 2023 Jun; 71(6):1937-1943. PubMed ID: 36786273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study.
    Dos Santos ANM; Junior GAAG; Benseñor IM; Goulart AC; Brunoni AR; Viana MC; Lotufo PA; Suemoto CK
    Eur J Clin Pharmacol; 2022 Sep; 78(9):1527-1534. PubMed ID: 35764818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
    Pasina L; Lucca U; Tettamanti M
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
    Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
    Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic and sedative medication use in older patients with cognitive concerns.
    Hinkle CE; Davis JD; Arias I; Goldstein A; Daiello L; Margolis SA
    J Am Geriatr Soc; 2024 Sep; 72(9):2792-2799. PubMed ID: 38685717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
    Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
    Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.